Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

This article explores the pharma quality management system, focusing on GMP compliance frameworks, quality risk management, CAPA effectiveness, and data integrity. It explains how modern pharmaceutical organizations build resilient quality systems to ensure inspection readiness and regulatory performance in highly
FDA launches one-day inspections and expands AI systems Elsa 4.0 and HALO at its headquarters in the United States, introducing a major shift in global pharmaceutical regulation. The move accelerates risk-based oversight and structured-data review, reshaping GMP expectations for manufacturers